Surgical treatment and results of 62 patients with epithelioid hemangioendothelioma of bone

Andrea Angelini, Andreas F. Mavrogenis, Marco Gambarotti, Biagio Merlino, Piero Picci, Pietro Ruggieri

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objective Purpose of this retrospective study was (1) to evaluate overall survival and survival to local recurrence of patients with unifocal and multifocal tumor and (2) to evaluate survival to local recurrence after intralesional or wide surgery. Material and Methods We reviewed 62 patients with epithelioid hemangioendothelioma of bone, treated from 1985 to 2010. Histological sections and immunohistochemistry were evaluated. Tumor presented as unifocal in 49 patients and as multifocal in 13. Results Mean follow-up was 9 years. Five patients (10%) with unifocal tumor progressed to multifocal. Overall survival was 92% at 10 years. Survival with unifocal tumor was significantly higher than survival with multifocal tumor. Survival to local recurrence was 76% at 10 years, significantly higher after wide resection than after intralesional surgery, while there was no statistical difference comparing unifocal and multifocal tumor. At multivariate analysis both variables showed no statistically significance. Conclusion Wide surgical excision reduces the risk of local recurrence, but functional results and morbidity need to be considered individually when defining surgical indications. Due to the risk of radiation-induced sarcomas, radiation therapy should be reserved to those cases not amenable to wide surgery or when lesions are seated locations difficult to treat.

Original languageEnglish
Pages (from-to)791-797
Number of pages7
JournalJournal of Surgical Oncology
Volume109
Issue number8
DOIs
Publication statusPublished - 2014

Fingerprint

Epithelioid Hemangioendothelioma
Bone and Bones
Survival
Recurrence
Neoplasms
Therapeutics
Sarcoma
Radiotherapy
Multivariate Analysis
Retrospective Studies
Immunohistochemistry
Radiation
Morbidity

Keywords

  • epithelioid hemangioendothelioma
  • hemangioendothelioma of bone
  • surgical treatment
  • survival
  • vascular tumors

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Surgical treatment and results of 62 patients with epithelioid hemangioendothelioma of bone. / Angelini, Andrea; Mavrogenis, Andreas F.; Gambarotti, Marco; Merlino, Biagio; Picci, Piero; Ruggieri, Pietro.

In: Journal of Surgical Oncology, Vol. 109, No. 8, 2014, p. 791-797.

Research output: Contribution to journalArticle

Angelini, Andrea ; Mavrogenis, Andreas F. ; Gambarotti, Marco ; Merlino, Biagio ; Picci, Piero ; Ruggieri, Pietro. / Surgical treatment and results of 62 patients with epithelioid hemangioendothelioma of bone. In: Journal of Surgical Oncology. 2014 ; Vol. 109, No. 8. pp. 791-797.
@article{5e3f4ada69c04a209b3113c408aeef44,
title = "Surgical treatment and results of 62 patients with epithelioid hemangioendothelioma of bone",
abstract = "Objective Purpose of this retrospective study was (1) to evaluate overall survival and survival to local recurrence of patients with unifocal and multifocal tumor and (2) to evaluate survival to local recurrence after intralesional or wide surgery. Material and Methods We reviewed 62 patients with epithelioid hemangioendothelioma of bone, treated from 1985 to 2010. Histological sections and immunohistochemistry were evaluated. Tumor presented as unifocal in 49 patients and as multifocal in 13. Results Mean follow-up was 9 years. Five patients (10{\%}) with unifocal tumor progressed to multifocal. Overall survival was 92{\%} at 10 years. Survival with unifocal tumor was significantly higher than survival with multifocal tumor. Survival to local recurrence was 76{\%} at 10 years, significantly higher after wide resection than after intralesional surgery, while there was no statistical difference comparing unifocal and multifocal tumor. At multivariate analysis both variables showed no statistically significance. Conclusion Wide surgical excision reduces the risk of local recurrence, but functional results and morbidity need to be considered individually when defining surgical indications. Due to the risk of radiation-induced sarcomas, radiation therapy should be reserved to those cases not amenable to wide surgery or when lesions are seated locations difficult to treat.",
keywords = "epithelioid hemangioendothelioma, hemangioendothelioma of bone, surgical treatment, survival, vascular tumors",
author = "Andrea Angelini and Mavrogenis, {Andreas F.} and Marco Gambarotti and Biagio Merlino and Piero Picci and Pietro Ruggieri",
year = "2014",
doi = "10.1002/jso.23587",
language = "English",
volume = "109",
pages = "791--797",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "John Wiley and Sons Inc.",
number = "8",

}

TY - JOUR

T1 - Surgical treatment and results of 62 patients with epithelioid hemangioendothelioma of bone

AU - Angelini, Andrea

AU - Mavrogenis, Andreas F.

AU - Gambarotti, Marco

AU - Merlino, Biagio

AU - Picci, Piero

AU - Ruggieri, Pietro

PY - 2014

Y1 - 2014

N2 - Objective Purpose of this retrospective study was (1) to evaluate overall survival and survival to local recurrence of patients with unifocal and multifocal tumor and (2) to evaluate survival to local recurrence after intralesional or wide surgery. Material and Methods We reviewed 62 patients with epithelioid hemangioendothelioma of bone, treated from 1985 to 2010. Histological sections and immunohistochemistry were evaluated. Tumor presented as unifocal in 49 patients and as multifocal in 13. Results Mean follow-up was 9 years. Five patients (10%) with unifocal tumor progressed to multifocal. Overall survival was 92% at 10 years. Survival with unifocal tumor was significantly higher than survival with multifocal tumor. Survival to local recurrence was 76% at 10 years, significantly higher after wide resection than after intralesional surgery, while there was no statistical difference comparing unifocal and multifocal tumor. At multivariate analysis both variables showed no statistically significance. Conclusion Wide surgical excision reduces the risk of local recurrence, but functional results and morbidity need to be considered individually when defining surgical indications. Due to the risk of radiation-induced sarcomas, radiation therapy should be reserved to those cases not amenable to wide surgery or when lesions are seated locations difficult to treat.

AB - Objective Purpose of this retrospective study was (1) to evaluate overall survival and survival to local recurrence of patients with unifocal and multifocal tumor and (2) to evaluate survival to local recurrence after intralesional or wide surgery. Material and Methods We reviewed 62 patients with epithelioid hemangioendothelioma of bone, treated from 1985 to 2010. Histological sections and immunohistochemistry were evaluated. Tumor presented as unifocal in 49 patients and as multifocal in 13. Results Mean follow-up was 9 years. Five patients (10%) with unifocal tumor progressed to multifocal. Overall survival was 92% at 10 years. Survival with unifocal tumor was significantly higher than survival with multifocal tumor. Survival to local recurrence was 76% at 10 years, significantly higher after wide resection than after intralesional surgery, while there was no statistical difference comparing unifocal and multifocal tumor. At multivariate analysis both variables showed no statistically significance. Conclusion Wide surgical excision reduces the risk of local recurrence, but functional results and morbidity need to be considered individually when defining surgical indications. Due to the risk of radiation-induced sarcomas, radiation therapy should be reserved to those cases not amenable to wide surgery or when lesions are seated locations difficult to treat.

KW - epithelioid hemangioendothelioma

KW - hemangioendothelioma of bone

KW - surgical treatment

KW - survival

KW - vascular tumors

UR - http://www.scopus.com/inward/record.url?scp=84900479175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900479175&partnerID=8YFLogxK

U2 - 10.1002/jso.23587

DO - 10.1002/jso.23587

M3 - Article

C2 - 24643837

AN - SCOPUS:84900479175

VL - 109

SP - 791

EP - 797

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 8

ER -